Sanofi Consumer Healthcare India Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Sanofi Consumer Healthcare India at Rs 4,523.6 is a listed entity that most Indian investors confuse with the much larger Sanofi India (a separate listed entity). Sanofi Consumer Healthcare focuses on OTC consumer healthcare brands including Allegra (antihistamine), Combiflam (painkiller), and Nastiflu, sold through pharmacy retail and increasingly through modern trade and e-commerce. The Sanofi Consumer Healthcare India share price target of Rs 5,615 for 2027, rising to Rs 8,335 by 2030, reflects the OTC healthcare premiumisation story.

The Sanofi Consumer Healthcare India share price target of Rs 5,620 for 2027, rising to Rs 8,320 by 2030, reflects 14% annual earnings growth with a forward multiple consistent with Pharma (OTC Consumer) peers. This article covers the Sanofi Consumer Healthcare India share price target 2027, 2028, and 2030 based on FY26 financials and analyst estimates as of August 2026.

Click Here – Get Free Investment Predictions

Sanofi Consumer Healthcare India Company Overview

Metric	Details
NSE Ticker	SANOFICONR
Sector	Pharma (OTC Consumer)
CMP (05 Aug 2026)	Rs 4523.6
52-Week High	Rs 5,800
52-Week Low	Rs 3,200
Market Cap	Rs 9,783 Cr
FY26 EPS	See rationale
Promoter Holding	72%
12M Consensus	₹5,855 (+29%)
Sanofi Consumer Healthcare India Share Price Target 2027	Rs 5,620 (+24%)
Sanofi Consumer Healthcare India Share Price Target 2028	Rs 6,400 (+41%)
Sanofi Consumer Healthcare India Share Price Target 2030	Rs 8,320 (+84%)
Bull Case 2030	Rs 10,650
Bear Case 2030	Rs 6,323

What most investors miss: Sanofi Consumer Healthcare India is distinct from the separately listed Sanofi India (prescription drug entity). This company focuses on OTC consumer health brands including Allegra, Combiflam, and Nastiflu, sold through pharmacy and modern trade. The parent Sanofi S.A. has been actively expanding OTC portfolios globally after separating the Consumer Healthcare segment (Opella) from the prescription business. This global strategy could eventually affect the Indian listed entity through product transfers or restructuring.

Valued at roughly 44x FY26 EPS (₹112. 0), with earnings expected to compound near 14% annually before slowing to approximately11%. The share price targets of Rs 5,620 for 2027, Rs 6,400 for 2028, and Rs 8,320 for 2030 are derived from this earnings trajectory and peer multiples.

Why Is the Sanofi Consumer Healthcare India Share Price Target Set at Rs 5,620 for 2027

Allegra and Combiflam Are Category-Leading OTC Healthcare Brands

This is the foundational driver of the Sanofi Consumer Healthcare India share price target of Rs 5,620 for 2027 and Rs 8,320 by 2030. Valued at roughly 44x FY26 EPS (₹112.0), with earnings expected to compound near 14% annually before slowing to approximately11%. Street consensus (1-yr) sits at ₹5,855. The market will progressively price this as quarterly data confirms the trajectory.

OTC Consumer Health Market Growth Accelerates Post-COVID Awareness

Investors analysing the Sanofi Consumer Healthcare India share price target should track this dimension quarterly, as it provides the clearest signal of whether the compounding thesis is on track. Evidence of sustained improvement in this area is the primary re-rating catalyst for the Sanofi Consumer Healthcare India share price target 2028 of Rs 6061.

E-Commerce and Modern Trade Channel Expansion Reaches New Urban Consumers

This structural factor is often underweighted in standard Sanofi Consumer Healthcare India share price target analyses, which focus on trailing earnings multiples rather than the competitive positioning embedded in the long-term franchise value. Its persistence through economic cycles is what differentiates the Sanofi Consumer Healthcare India share price target 2030 case from a short-term trading call.

Global Sanofi Opella OTC Strategy Could Enhance India Product Portfolio

For the Sanofi Consumer Healthcare India share price target of Rs 8,320 to materialise by 2030, this factor needs to remain intact and compound over 4 years. Quarterly updates on this metric provide the earliest warning signal of any deviation from the Sanofi Consumer Healthcare India share price target base case assumptions.

Debt-Free Balance Sheet With Consistent Dividend History Provides Carry

As India's economy compounds through 2027 to 2030, this factor provides an additional secular tailwind that is layered on top of the Sanofi Consumer Healthcare India-specific earnings growth already embedded in the Rs 5,620 target for 2027 and the Rs 8,320 target for 2030.

Sanofi Consumer Healthcare India Share Price Targets 2027, 2028 and 2030

Sanofi Consumer Healthcare India Share Price Target 2027: Rs 5,620

The Sanofi Consumer Healthcare India share price target 2027 is Rs 5,620, representing approximately 24 percent upside from CMP Rs 4523.6. Valued at roughly 44x FY26 EPS (₹112.0), with earnings expected to compound near 14% annually before slowing to approximately11%. Street consensus (1-yr) sits at ₹5,855.. By 2027, the key catalyst for achieving this level is validation of the earnings trajectory through 2 consecutive quarters of on-target performance.

Sanofi Consumer Healthcare India Share Price Target 2028: Rs 6,400

The Sanofi Consumer Healthcare India share price target 2028 is Rs 6,400, implying approximately 41 percent upside from CMP. By 2028, Sanofi Consumer Healthcare India should have demonstrated through a full earnings cycle that the 14% growth assumption is sustainable, supporting a re-rating toward the Sanofi Consumer Healthcare India share price target 2028 level at a forward multiple consistent with sector peers.

Sanofi Consumer Healthcare India Share Price Target 2030: Rs 8,320

The Sanofi Consumer Healthcare India share price target 2030 is Rs 8,320, implying approximately 84 percent upside from CMP and a 4-year CAGR of approximately 16% from current levels. By 2030, Sanofi Consumer Healthcare India should be a mature, well-understood franchise with a track record of consistent compounding that justifies the target multiple.

Bull Case and Bear Case for the Sanofi Consumer Healthcare India Share Price Target 2030

Bull Case: Rs 10,650

The bull case Sanofi Consumer Healthcare India share price target of Rs 10,650 by 2030: Rs 10,500 by 2030, if the global Opella OTC strategy transfers new premium healthcare products to the Indian listed entity and OTC market growth accelerates above 15 percent annually.

Bear Case: Rs 6,323

The bear case Sanofi Consumer Healthcare India share price target of Rs 6,323 by 2030: Rs 6,500 by 2030, if OTC market growth reverts to single digits as the post-COVID healthcare awareness peak normalises, and Sanofi's global Opella strategy does not materially benefit the Indian subsidiary.

Scenario	Target by 2030	Return	Key Assumption
Bull Case	Rs 10,650	+135%	Upside scenario with favourable execution and sector conditions
Base Case	Rs 8,320	+84%	14% EPS CAGR; peer-multiple sustained through FY31
Bear Case	Rs 6,323	+40%	Downside scenario with adverse execution or macro headwinds

Key Risks to the Sanofi Consumer Healthcare India Share Price Target

USFDA Inspection and Compliance Risk

Any USFDA warning letter or import alert on Sanofi Consumer Healthcare India's manufacturing facilities would delay product launches and revenue recognition, directly reducing the earnings trajectory behind the Sanofi Consumer Healthcare India share price target. USFDA inspection history is the most important risk indicator to track.

Currency Risk on Export Revenue

Sanofi Consumer Healthcare India's international revenue is primarily in US dollars and euros. Any significant INR appreciation against these currencies would reduce the INR value of reported revenues and EPS, compressing the Sanofi Consumer Healthcare India share price target earnings assumptions.

Pricing Pressure in Regulated Generic Markets

In the US and EU generic markets, pricing erosion from competition intensifies as multiple players receive approvals for the same molecule. Any acceleration in generic pricing erosion in Sanofi Consumer Healthcare India's key export products would compress the Sanofi Consumer Healthcare India share price target revenue base.

Clinical Trial and Pipeline Risk

Any setback in Sanofi Consumer Healthcare India's clinical trial results or regulatory approvals for pipeline products would delay the revenue ramp from specialty or novel products embedded in the Sanofi Consumer Healthcare India share price target 2028 and 2030 assumptions.

How to Invest in Sanofi Consumer Healthcare India

Use the Univest Screener to track Sanofi Consumer Healthcare India's key financial metrics including EPS growth, margin trends, and analyst upgrades or downgrades in real time. To purchase shares, open a demat account with any SEBI-registered broker and search for NSE ticker SANOFICONR. Review the quarterly earnings data, the sector-specific risk indicators outlined in this article, and build a position size proportionate to your risk tolerance and investment horizon. Monitor each quarter for the key variables most likely to move the Sanofi Consumer Healthcare India share price target. Consult a SEBI-registered financial advisor before making any investment decision.

Use the Univest Screener to Track This Stock Live

Conclusion

The Sanofi Consumer Healthcare India share price target of Rs 5,620 for 2027, Rs 6,400 for 2028, and Rs 8,320 for 2030 reflects 14% annual earnings compounding and a forward multiple consistent with Pharma (OTC Consumer) peers. The key drivers and risks are outlined above. Sanofi Consumer Healthcare India is distinct from the separately listed Sanofi India (prescription drug entity). This company focuses on OTC consumer. For investors with a 3 to 4 year horizon and a tolerance for Pharma (OTC Consumer)-specific risk, the current CMP of Rs 4523.6 offers a starting point for building a position aligned to the Sanofi Consumer Healthcare India share price target 2030 thesis. Always verify data at NSE and BSE before investing.

Download the Univest iOS App or Univest Android App to track Sanofi Consumer Healthcare India share price live and get daily stock recommendations.

Frequently Asked Questions on Sanofi Consumer Healthcare India Share Price Target 2027 2028 and 2030

What is the Sanofi Consumer Healthcare India share price target for 2027?

Ans. The Sanofi Consumer Healthcare India share price target for 2027 is Rs 5,620, representing approximately 24 percent upside from CMP Rs 4523.6 as of August 2026. Please verify all data with the official NSE website before making any investment decision.

What is the Sanofi Consumer Healthcare India share price target for 2030?

Ans. The Sanofi Consumer Healthcare India share price target for 2030 is Rs 8,320, implying approximately 84 percent upside from CMP Rs 4523.6. This is based on analyst estimates and is not a guaranteed return. Always verify current data at NSE India before investing.

Is Sanofi Consumer Healthcare India a good long-term investment?

Ans. Sanofi Consumer Healthcare India has a defined analyst consensus that projects earnings compounding through FY31 based on sector-specific growth drivers outlined in this article. Whether it suits your portfolio depends on your risk appetite, investment horizon, and existing allocation. Consult a SEBI-registered financial advisor for personalised guidance.

What do most investors miss about Sanofi Consumer Healthcare India?

Ans. Pure-play OTC entity demerged from Sanofi India (2023-24) running an asset-light/toll-manufactured model (hence 90% ROCE); earnings hinge on continued brand-licence terms with parent Sanofi for flagship brands (Allegra, Combiflam, Avil, De-Pura) and free float is thin at only 28.7%.

What is the bull case for the Sanofi Consumer Healthcare India share price target 2030?

Ans. The bull case Sanofi Consumer Healthcare India share price target for 2030 is Rs 10,650. This requires better-than-base-case execution on the key growth drivers specific to Sanofi Consumer Healthcare India's sector, as described in this article. These are analyst projections, not guaranteed returns.

What are the main risks to the Sanofi Consumer Healthcare India share price target?

Ans. The key risks to the Sanofi Consumer Healthcare India share price target include sector-specific headwinds such as credit cycles (for financial companies), regulatory changes, competitive pressure, and macroeconomic slowdown. Please review the risks section of this article for a full breakdown of the four most material risks.

What is Sanofi Consumer Healthcare India's 52-week high and low share price?

Ans. As of August 2026, Sanofi Consumer Healthcare India's 52-week high is approximately Rs 5,800 and the 52-week low is approximately Rs 3,200. The CMP of Rs 4523.6 sits between these levels. Always verify the latest 52-week data at NSE India or BSE before making any investment decision.

How can I buy Sanofi Consumer Healthcare India shares?

Ans. You can buy Sanofi Consumer Healthcare India shares through any SEBI-registered broker by searching for the NSE ticker SANOFICONR. Before investing, review the fundamentals outlined in this article and consult a SEBI-registered financial advisor for guidance aligned to your specific financial goals.